Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16570047

Br. J. Cancer 2006 Apr 24 94 8 1136-43

Download in:

View as

Triples

General Info

PMID
16570047